Teachers Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Teachers Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$848K	Buy	48,364 +4,874	+11%	+$76.9K	﹤0.01%	2356
2018 Q4	$645K	Hold	43,490	–	–	﹤0.01%	2399
2018 Q3	$1.07M	Buy	43,490 +3,541	+9%	+$76.8K	﹤0.01%	2277
2018 Q2	$784K	Buy	+39,949	New	+$756K	﹤0.01%	2456
2017 Q2	–	Sell	-11,183	Closed	-$89K	–	3156
2017 Q1	$89K	Buy	11,183 +4,033	+56%	+$27.1K	﹤0.01%	2993
2016 Q4	$174K	Hold	7,150	–	–	﹤0.01%	2930
2016 Q3	$271K	Hold	7,150	–	–	﹤0.01%	2755
2016 Q2	$213K	Buy	+7,150	New	+$251K	﹤0.01%	2874

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teachers Advisors's RCKT Position: Q1 2019 in Review

Teachers Advisors increased its Rocket Pharmaceuticals (RCKT) stake by 11% in Q1 2019, buying an estimated $76.9K and bringing the position to 48,364 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

Teachers Advisors first reported a position in RCKT in Q2 2016 and has held it in 8 quarters since. The position peaked at $1.07M in Q3 2018. 81 funds tracked by Wall St. Rank hold RCKT as of Q1 2019.

Teachers Advisors held 48,364 shares of Rocket Pharmaceuticals worth $848K as of Q1 2019.
Teachers Advisors bought 4,874 Rocket Pharmaceuticals shares in Q1 2019, an estimated $76.9K.
Rocket Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2356 holding.
Teachers Advisors first reported a position in Rocket Pharmaceuticals in Q2 2016 and has held it in 8 quarters since.
Teachers Advisors's Rocket Pharmaceuticals position peaked at $1.07M in Q3 2018.
81 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.